期刊文献+

中医络风内动证的病变特征和炎症标志物的检测 被引量:37

Angiographic morphology of coronary artery lesions and level of plasma inflammatory markers in patients with endogenous collateral wind
原文传递
导出
摘要 目的采用冠状动脉造影(CAG)结合测定患者血浆炎症标志物水平,初步探讨中医络风内动证的病变特征和炎症机制。方法入选CAG显示为单支血管病变的冠心病患者/20例,按中医辨证分为血瘀证组(30例)、痰阻血瘀证组(30例)和络风内动证组(60例)。采用酶联免疫吸附法测定患者血浆高敏C反应蛋白(hs—CRP)、金属基质蛋白酶-2,-9(MMP-2,MMP-9)、CD40配体(CD40L)和妊娠相关蛋白-A(PAPP—A)水平。使用软件包SPSS11.0对3组资料进行统计学处理。结果络风内动证组血管狭窄程度以95%-99%为主,主要表现ACC/AHA的B2、C型病变以及Levin分型的Ⅱ型病变,与血瘀证组和痰阻血瘀证组比较差异显著(P〈0.05)。络风内动证组患者血浆MMP-2、MMP-9和PAPP-A水平均显著高于血瘀证组(P〈0.01)和痰阻血瘀证组(P〈0.05)。络风内动证组线性相关分析表明:MMP-2与hs—CRP(r=0.486,P〈0.05)、PAPP—A(r=0.544,P〈0.05)均呈显著正相关,CD40L与PAPP—A也呈显著正相关(r=0.766,P〈0.01)。结论络风内动证组与其它证组相比,患者冠状动脉病变严重而复杂,血浆炎症标志物水平高。 AIM To study the features of coronary artery lesions by coronary angiography (CAG) and the inflammatory mechanisms by the levels of plasma inflammatory markers in patients with endogenous collateral wind differentiated by traditional Chinese medicine (TCM). METHODS One hundred and twenty consecutive patients with single blood vessel lesions confirmed by CAG were randomly divided into 3 groups based on the different types of syndrome differentiated by TCM: blood stasis group (n = 30) , blood stasis due to phlegm obstruction group (n = 30) and endogenous collateral wind group (n = 60). The levels of plasma inflammatory markers such as high sensitivity C-reactive protein (hs-CRP), matrix metalloproteinase (MMP, including MMP-2 and MMP-9) , CD40 ligand (CD40L) and pregnancy associated plasma protein-A (PAPP-A) were measured by enzyme linked immunosorbent assay (ELISA). Analyses were performed by statistical package SPSS11. 0. RESULTS Angiostenosis in endogenous collateral wind group was 90%-95% , mainly of B2, C of ACC/AHA type lesion and Ⅱ Levin type lesion, which were higher than those in the other two groups (P 〈 0. 05 respectively). The levels of plasma MMP-2, MMP-9 and PAPP-A in endogenous collateral wind group were significantly higher than those in blood stasis group (P 〈0.01 ) and blood stasis due to phlegm obstruction group (P 〈0. 05). In endogenous collateral wind group, linear correlation analysis manifested that MMP-2 was positively and significantly associated with hs-CRP ( r = 0. 486, P 〈 0. 05 ) and PAPP-A ( r = 0. 544, P 〈 0.05 ). CD40L was also positively and significantly associated with PAPP-A ( r = 0. 766, P 〈 0. 01 ). CONCLUSION Compared with those in blood stasis group and blood stasis due to phlegm obstruction group, the coronary artery lesions are more severe and complex and the levels of plasma inflammatory markers are higher in endogenous collateral wind group.
出处 《心脏杂志》 CAS 2008年第5期619-621,626,共4页 Chinese Heart Journal
基金 北京中医药科技基金项目资助(2002WX)
关键词 冠状动脉疾病 冠状动脉造影 血浆炎症标志物水平 中医辨证分型 coronary disease coronary angiography levels of plasma inflammatory markers different type of syndrome differentiated by traditional Chinese medicine
  • 相关文献

参考文献8

  • 1王显 杨巨成.急性冠脉综合征“络风内动”假说及实践.中华中医药杂志,2002,17(9):19-22.
  • 2王显 杨巨成.急性冠脉综合征“络风内动”假说再认识.中华中医药杂志,2002,17(10):8-10.
  • 3王显,林钟香,葛均波,张振贤,沈琳.Relationship between Traditional Chinese Medicine Syndrome Type and Coronary Arteriography of Acute Coronary Syndrome[J].Chinese Journal of Integrated Traditional and Western Medicine,2003,9(2):116-119. 被引量:30
  • 4王显,胡大一.急性冠脉综合征“络风内动”假说临床研究[J].中华中医药杂志,2008,23(3):204-208. 被引量:86
  • 5王显,胡大一,杨士伟,张健,谭琛,张守彦.冠状动脉斑块形态学与血浆炎症介质的关系[J].中华内科杂志,2008,47(1):27-30. 被引量:24
  • 6中国中西医结合学会心血管学会.冠心病中医辨证标准[J].中西医结合杂志,1991,11(5):257-257.
  • 7中国中西医结合学会活血化瘀专业委员会.血瘀证判断标准[J].中西医结合杂志,1987,7(3):129-129.
  • 8Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for pereutaneous coronary, intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions [ J]. Circulation, 2001, 103 (24) :3019 -41.

二级参考文献17

  • 1[1]MA CS,GAI LY,ZHANG KJ,et al. Intervention Cardiology.Beijing: Publishing House of People's Health,1998∶385-336.
  • 2[2]ACC/AHA Task Force.Guidelines for percutaneous transluminal coronary angioplasty.A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures(Subcommittee on Percutaneous Transluminal Coronary Angioplasty).J Am Coll Cardiol 1988;12∶529.
  • 3[3]Cardiovascular Committee of Chinese Association of the Integration of Traditional and Western Medicine.Criteria for TCM Syndrome differentiation of coronary heart disease.Chin J of Integr Tradi West Med (Chin) 1991;11(5)∶257.
  • 4[4]The Committee of Promoting Blood Circulation to Remove Stasis,China Association of the Integration of Traditional and Western Medicine.Criteria for diagnosis of blood stasis syndrome. Chin J of Integr Tradi West Med(Chin) 1987;7(3)∶129.
  • 5[5]XU XL,GUO YJ,CHEN DM. Atlas of coronary artery disease(Williams MJ edit.).Tianjin: Tianjin Science and Technology Translation Publishing Co.,2001∶44.
  • 6van der Wal AC, Becker AE. Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovasc Res, 1999,41:334-344.
  • 7Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med, 1987,316 : 1371-1375.
  • 8Hermiller JB, Tenaglia AN, Kisslo KB,et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol, 1993,71:665-668.
  • 9Schoenhagen P, Ziada KM, Kapadia SR, et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study. Circulation, 2000, 101:598-603.
  • 10Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention ( revision of the 1993 PTCA guidelines ) -executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation, 2001,103:3019-3041.

共引文献372

同被引文献333

引证文献37

二级引证文献410

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部